Do you want to read an article? Please log in or register.
Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration
Macular DiseasesFurther Publications
Related content
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study
Acta Ophthalmol
Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I
doi: 10.1111/aos.17534
Macular Diseases
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease
JAMA Ophthalmol
Hallak JA, Abbasi A, Goldberg RA, Modi Y, Zhao C, Jing Y, Chen N, Mercer D, Sahu S, Alobaidi A, López FJ, Luhrs K, Waring JF, den Hollander AI, Smaoui N
doi: 10.1001/jamaophthalmol.2024.2376
COMMENTED
Macular Diseases
Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: AREDS2 Report 34
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Duic C, Vance E, Agrón E, Keenan TDL, AREDS2 Research Group
doi: 10.1016/j.oret.2024.11.006
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol
Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH
doi: 10.1001/jamaophthalmol.2025.1455
Macular Diseases
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Br J Ophthalmol
Vu TA, Fenwick EK, Man REK, Thakur S, Tan ACS, Cheung CMG, Gupta P, Lamoureux EL
doi: 10.1136/bjo-2024-325713
Macular DiseasesFurther Publications
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study
Ophthalmol Sci
Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D
doi: 10.1016/j.xops.2024.100565
Macular Diseases
Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence
Sci Rep
Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR
doi: 10.1038/s41598-024-78327-0
Macular Diseases
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration
JAMA Ophthalmol
Lynch AM, Grove NC, Wagner BD, Palestine AG, Holers VM, Frazer-Abel AA, Gnanaraj R, Lisker-Cervantes A, Patnaik JL, de Carlo Forest TE, Auer EA, McReynolds AJ, Mathias MT, Manoharan N, Rodriquez De Cordoba S, Mandava N
doi: 10.1001/jamaophthalmol.2025.1608